‘One of the scariest things I've seen': Legal expert alarmed by TrumpRx
U.S. President Donald Trump reacts on the day he announces a deal with Pfizer to sell drugs at lower prices, in the Oval office of the White House in Washington, D.C. on Sept. 30, 2025. REUTERS/Ken Cedeno

A legal expert is warning people about using TrumpRx, calling it "one of the scariest things I've seen in 2025 — and that's saying a lot."

Eliza Orlins, a public defender and former Manhattan DA candidate, explained in an Instagram reel why people should not give the Trump administration access to prescriptions or medical history on the new platform, claiming "to help you get prescriptions cheaper, but it's not what it seems and I am begging you, do not enter your medical information into this Trump-backed website."

President Donald Trump on Tuesday announced an agreement with pharmaceutical maker Pfizer and debuted TrumpRx, claiming he would offer discounted drugs with a new direct-to-consumer website.

It "sounds great on paper," but generally benefits people who do not have insurance and won't leave most Americans better off, Orlins argues.

"But here is the real catch: privacy... in order to use this site you'd have to tell the government exactly what medications you take, what conditions you have, when you refill them, everything about yourself, including your medical history, it could be mental health meds, HIV meds, reproductive health meds — everything tied to your name," she explains. "And the White House hasn't said what data they'll collect, how it will be stored, who gets access or what happens when the program ends. How are they going to use this information?"

But the reality of these discounts is still unknown, along with what the administration will do with this information, she added.

"And this discount comes at a cost. That cost is your privacy. Because once you hand over this information, it is theirs forever, and you will never know where it went.

"I think it's one of the biggest things that we'll do," the president said. "We'll be reducing drug prices by 100% in some cases, 300% or more."